Industry Research Reports

Home > Reports > Medical Devices & Consumables > Insulin Dosing Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Insulin Dosing Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Devices & Consumables

Published: 2024-01-11

Pages: 130 Pages

Report ld: 2638899

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Insulin Dosing Device was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Insulin Dosing Device, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Insulin Dosing Device by region & country, by Type, and by Application.

The Insulin Dosing Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Dosing Device.

Market Segmentation

Report Metric
Details
Report Title
Insulin Dosing Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Insulin Dosing Device Companies Covered
Novo Nordisk, Sanofi, BD, Eli Lilly, Medtronic, Beta Bionics, Copernicus, Dance Biopharm, Debiotech, Insulet, MannKind, Owen Mumford, Roche, SOOIL, Tandem Diabetes Care, Valeritas, West Pharma, Ypsomed
Global Insulin Dosing Device Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Insulin Dosing Device Market, Segment by Type
Insulin Pens

Insulin Pumps

Insulin Syringes

Others
Global Insulin Dosing Device Market, Segment by Application
Hospital

Clinic

Home Care

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Insulin Dosing Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Insulin Dosing Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Insulin Dosing Device in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Insulin Dosing Device Product Introduction
    1.2 Global Insulin Dosing Device Market Size Forecast
        1.2.1 Global Insulin Dosing Device Sales Value (2019-2030)
        1.2.2 Global Insulin Dosing Device Sales Volume (2019-2030)
        1.2.3 Global Insulin Dosing Device Sales Price (2019-2030)
    1.3 Insulin Dosing Device Market Trends & Drivers
        1.3.1 Insulin Dosing Device Industry Trends
        1.3.2 Insulin Dosing Device Market Drivers & Opportunity
        1.3.3 Insulin Dosing Device Market Challenges
        1.3.4 Insulin Dosing Device Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Insulin Dosing Device Players Revenue Ranking (2023)
    2.2 Global Insulin Dosing Device Revenue by Company (2019-2024)
    2.3 Global Insulin Dosing Device Players Sales Volume Ranking (2023)
    2.4 Global Insulin Dosing Device Sales Volume by Company Players (2019-2024)
    2.5 Global Insulin Dosing Device Average Price by Company (2019-2024)
    2.6 Key Manufacturers Insulin Dosing Device Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Insulin Dosing Device Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Insulin Dosing Device
    2.9 Insulin Dosing Device Market Competitive Analysis
        2.9.1 Insulin Dosing Device Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Insulin Dosing Device Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Dosing Device as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Insulin Pens
        3.1.2 Insulin Pumps
        3.1.3 Insulin Syringes
        3.1.4 Others
    3.2 Global Insulin Dosing Device Sales Value by Type
        3.2.1 Global Insulin Dosing Device Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Insulin Dosing Device Sales Value, by Type (2019-2030)
        3.2.3 Global Insulin Dosing Device Sales Value, by Type (%) (2019-2030)
    3.3 Global Insulin Dosing Device Sales Volume by Type
        3.3.1 Global Insulin Dosing Device Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Insulin Dosing Device Sales Volume, by Type (2019-2030)
        3.3.3 Global Insulin Dosing Device Sales Volume, by Type (%) (2019-2030)
    3.4 Global Insulin Dosing Device Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospital
        4.1.2 Clinic
        4.1.3 Home Care
        4.1.4 Others
    4.2 Global Insulin Dosing Device Sales Value by Application
        4.2.1 Global Insulin Dosing Device Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Insulin Dosing Device Sales Value, by Application (2019-2030)
        4.2.3 Global Insulin Dosing Device Sales Value, by Application (%) (2019-2030)
    4.3 Global Insulin Dosing Device Sales Volume by Application
        4.3.1 Global Insulin Dosing Device Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Insulin Dosing Device Sales Volume, by Application (2019-2030)
        4.3.3 Global Insulin Dosing Device Sales Volume, by Application (%) (2019-2030)
    4.4 Global Insulin Dosing Device Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Insulin Dosing Device Sales Value by Region
        5.1.1 Global Insulin Dosing Device Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Insulin Dosing Device Sales Value by Region (2019-2024)
        5.1.3 Global Insulin Dosing Device Sales Value by Region (2025-2030)
        5.1.4 Global Insulin Dosing Device Sales Value by Region (%), (2019-2030)
    5.2 Global Insulin Dosing Device Sales Volume by Region
        5.2.1 Global Insulin Dosing Device Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Insulin Dosing Device Sales Volume by Region (2019-2024)
        5.2.3 Global Insulin Dosing Device Sales Volume by Region (2025-2030)
        5.2.4 Global Insulin Dosing Device Sales Volume by Region (%), (2019-2030)
    5.3 Global Insulin Dosing Device Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Insulin Dosing Device Sales Value, 2019-2030
        5.4.2 North America Insulin Dosing Device Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Insulin Dosing Device Sales Value, 2019-2030
        5.5.2 Europe Insulin Dosing Device Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Insulin Dosing Device Sales Value, 2019-2030
        5.6.2 Asia Pacific Insulin Dosing Device Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Insulin Dosing Device Sales Value, 2019-2030
        5.7.2 South America Insulin Dosing Device Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Insulin Dosing Device Sales Value, 2019-2030
        5.8.2 Middle East & Africa Insulin Dosing Device Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Insulin Dosing Device Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Insulin Dosing Device Sales Value
        6.2.1 Key Countries/Regions Insulin Dosing Device Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Insulin Dosing Device Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Insulin Dosing Device Sales Value, 2019-2030
        6.3.2 United States Insulin Dosing Device Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Insulin Dosing Device Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Insulin Dosing Device Sales Value, 2019-2030
        6.4.2 Europe Insulin Dosing Device Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Insulin Dosing Device Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Insulin Dosing Device Sales Value, 2019-2030
        6.5.2 China Insulin Dosing Device Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Insulin Dosing Device Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Insulin Dosing Device Sales Value, 2019-2030
        6.6.2 Japan Insulin Dosing Device Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Insulin Dosing Device Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Insulin Dosing Device Sales Value, 2019-2030
        6.7.2 South Korea Insulin Dosing Device Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Insulin Dosing Device Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Insulin Dosing Device Sales Value, 2019-2030
        6.8.2 Southeast Asia Insulin Dosing Device Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Insulin Dosing Device Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Insulin Dosing Device Sales Value, 2019-2030
        6.9.2 India Insulin Dosing Device Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Insulin Dosing Device Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Novo Nordisk
        7.1.1 Novo Nordisk Company Information
        7.1.2 Novo Nordisk Introduction and Business Overview
        7.1.3 Novo Nordisk Insulin Dosing Device Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Novo Nordisk Insulin Dosing Device Product Offerings
        7.1.5 Novo Nordisk Recent Development
    7.2 Sanofi
        7.2.1 Sanofi Company Information
        7.2.2 Sanofi Introduction and Business Overview
        7.2.3 Sanofi Insulin Dosing Device Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Sanofi Insulin Dosing Device Product Offerings
        7.2.5 Sanofi Recent Development
    7.3 BD
        7.3.1 BD Company Information
        7.3.2 BD Introduction and Business Overview
        7.3.3 BD Insulin Dosing Device Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 BD Insulin Dosing Device Product Offerings
        7.3.5 BD Recent Development
    7.4 Eli Lilly
        7.4.1 Eli Lilly Company Information
        7.4.2 Eli Lilly Introduction and Business Overview
        7.4.3 Eli Lilly Insulin Dosing Device Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Eli Lilly Insulin Dosing Device Product Offerings
        7.4.5 Eli Lilly Recent Development
    7.5 Medtronic
        7.5.1 Medtronic Company Information
        7.5.2 Medtronic Introduction and Business Overview
        7.5.3 Medtronic Insulin Dosing Device Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Medtronic Insulin Dosing Device Product Offerings
        7.5.5 Medtronic Recent Development
    7.6 Beta Bionics
        7.6.1 Beta Bionics Company Information
        7.6.2 Beta Bionics Introduction and Business Overview
        7.6.3 Beta Bionics Insulin Dosing Device Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Beta Bionics Insulin Dosing Device Product Offerings
        7.6.5 Beta Bionics Recent Development
    7.7 Copernicus
        7.7.1 Copernicus Company Information
        7.7.2 Copernicus Introduction and Business Overview
        7.7.3 Copernicus Insulin Dosing Device Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Copernicus Insulin Dosing Device Product Offerings
        7.7.5 Copernicus Recent Development
    7.8 Dance Biopharm
        7.8.1 Dance Biopharm Company Information
        7.8.2 Dance Biopharm Introduction and Business Overview
        7.8.3 Dance Biopharm Insulin Dosing Device Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Dance Biopharm Insulin Dosing Device Product Offerings
        7.8.5 Dance Biopharm Recent Development
    7.9 Debiotech
        7.9.1 Debiotech Company Information
        7.9.2 Debiotech Introduction and Business Overview
        7.9.3 Debiotech Insulin Dosing Device Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Debiotech Insulin Dosing Device Product Offerings
        7.9.5 Debiotech Recent Development
    7.10 Insulet
        7.10.1 Insulet Company Information
        7.10.2 Insulet Introduction and Business Overview
        7.10.3 Insulet Insulin Dosing Device Sales, Revenue and Gross Margin (2019-2024)
        7.10.4 Insulet Insulin Dosing Device Product Offerings
        7.10.5 Insulet Recent Development
    7.11 MannKind
        7.11.1 MannKind Company Information
        7.11.2 MannKind Introduction and Business Overview
        7.11.3 MannKind Insulin Dosing Device Sales, Revenue and Gross Margin (2019-2024)
        7.11.4 MannKind Insulin Dosing Device Product Offerings
        7.11.5 MannKind Recent Development
    7.12 Owen Mumford
        7.12.1 Owen Mumford Company Information
        7.12.2 Owen Mumford Introduction and Business Overview
        7.12.3 Owen Mumford Insulin Dosing Device Sales, Revenue and Gross Margin (2019-2024)
        7.12.4 Owen Mumford Insulin Dosing Device Product Offerings
        7.12.5 Owen Mumford Recent Development
    7.13 Roche
        7.13.1 Roche Company Information
        7.13.2 Roche Introduction and Business Overview
        7.13.3 Roche Insulin Dosing Device Sales, Revenue and Gross Margin (2019-2024)
        7.13.4 Roche Insulin Dosing Device Product Offerings
        7.13.5 Roche Recent Development
    7.14 SOOIL
        7.14.1 SOOIL Company Information
        7.14.2 SOOIL Introduction and Business Overview
        7.14.3 SOOIL Insulin Dosing Device Sales, Revenue and Gross Margin (2019-2024)
        7.14.4 SOOIL Insulin Dosing Device Product Offerings
        7.14.5 SOOIL Recent Development
    7.15 Tandem Diabetes Care
        7.15.1 Tandem Diabetes Care Company Information
        7.15.2 Tandem Diabetes Care Introduction and Business Overview
        7.15.3 Tandem Diabetes Care Insulin Dosing Device Sales, Revenue and Gross Margin (2019-2024)
        7.15.4 Tandem Diabetes Care Insulin Dosing Device Product Offerings
        7.15.5 Tandem Diabetes Care Recent Development
    7.16 Valeritas
        7.16.1 Valeritas Company Information
        7.16.2 Valeritas Introduction and Business Overview
        7.16.3 Valeritas Insulin Dosing Device Sales, Revenue and Gross Margin (2019-2024)
        7.16.4 Valeritas Insulin Dosing Device Product Offerings
        7.16.5 Valeritas Recent Development
    7.17 West Pharma
        7.17.1 West Pharma Company Information
        7.17.2 West Pharma Introduction and Business Overview
        7.17.3 West Pharma Insulin Dosing Device Sales, Revenue and Gross Margin (2019-2024)
        7.17.4 West Pharma Insulin Dosing Device Product Offerings
        7.17.5 West Pharma Recent Development
    7.18 Ypsomed
        7.18.1 Ypsomed Company Information
        7.18.2 Ypsomed Introduction and Business Overview
        7.18.3 Ypsomed Insulin Dosing Device Sales, Revenue and Gross Margin (2019-2024)
        7.18.4 Ypsomed Insulin Dosing Device Product Offerings
        7.18.5 Ypsomed Recent Development

 8 Industry Chain Analysis
    8.1 Insulin Dosing Device Industrial Chain
    8.2 Insulin Dosing Device Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Insulin Dosing Device Sales Model
        8.5.2 Sales Channel
        8.5.3 Insulin Dosing Device Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Insulin Dosing Device Market Trends
    Table 2. Insulin Dosing Device Market Drivers & Opportunity
    Table 3. Insulin Dosing Device Market Challenges
    Table 4. Insulin Dosing Device Market Restraints
    Table 5. Global Insulin Dosing Device Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Insulin Dosing Device Revenue Market Share by Company (2019-2024)
    Table 7. Global Insulin Dosing Device Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Insulin Dosing Device Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Insulin Dosing Device Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Insulin Dosing Device Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Insulin Dosing Device Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Insulin Dosing Device
    Table 13. Global Insulin Dosing Device Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Dosing Device as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Insulin Dosing Device Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Insulin Dosing Device Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Insulin Dosing Device Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Insulin Dosing Device Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Insulin Dosing Device Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Insulin Dosing Device Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Insulin Dosing Device Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Insulin Dosing Device Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Insulin Dosing Device Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Insulin Dosing Device Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Insulin Dosing Device Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Insulin Dosing Device Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Insulin Dosing Device Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Insulin Dosing Device Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Insulin Dosing Device Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Insulin Dosing Device Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Insulin Dosing Device Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Insulin Dosing Device Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Insulin Dosing Device Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Insulin Dosing Device Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Insulin Dosing Device Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Insulin Dosing Device Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Insulin Dosing Device Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Insulin Dosing Device Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Insulin Dosing Device Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Insulin Dosing Device Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Insulin Dosing Device Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Insulin Dosing Device Sales Value by Region (2019-2024) & (%)
    Table 44. Global Insulin Dosing Device Sales Value by Region (2025-2030) & (%)
    Table 45. Global Insulin Dosing Device Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Insulin Dosing Device Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Insulin Dosing Device Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Insulin Dosing Device Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Insulin Dosing Device Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Insulin Dosing Device Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Insulin Dosing Device Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Insulin Dosing Device Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Insulin Dosing Device Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Insulin Dosing Device Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Insulin Dosing Device Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Insulin Dosing Device Sales Volume, (2025-2030) & (K Units)
    Table 57. Novo Nordisk Company Information
    Table 58. Novo Nordisk Introduction and Business Overview
    Table 59. Novo Nordisk Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Novo Nordisk Insulin Dosing Device Product Offerings
    Table 61. Novo Nordisk Recent Development
    Table 62. Sanofi Company Information
    Table 63. Sanofi Introduction and Business Overview
    Table 64. Sanofi Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Sanofi Insulin Dosing Device Product Offerings
    Table 66. Sanofi Recent Development
    Table 67. BD Company Information
    Table 68. BD Introduction and Business Overview
    Table 69. BD Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. BD Insulin Dosing Device Product Offerings
    Table 71. BD Recent Development
    Table 72. Eli Lilly Company Information
    Table 73. Eli Lilly Introduction and Business Overview
    Table 74. Eli Lilly Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Eli Lilly Insulin Dosing Device Product Offerings
    Table 76. Eli Lilly Recent Development
    Table 77. Medtronic Company Information
    Table 78. Medtronic Introduction and Business Overview
    Table 79. Medtronic Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Medtronic Insulin Dosing Device Product Offerings
    Table 81. Medtronic Recent Development
    Table 82. Beta Bionics Company Information
    Table 83. Beta Bionics Introduction and Business Overview
    Table 84. Beta Bionics Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Beta Bionics Insulin Dosing Device Product Offerings
    Table 86. Beta Bionics Recent Development
    Table 87. Copernicus Company Information
    Table 88. Copernicus Introduction and Business Overview
    Table 89. Copernicus Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Copernicus Insulin Dosing Device Product Offerings
    Table 91. Copernicus Recent Development
    Table 92. Dance Biopharm Company Information
    Table 93. Dance Biopharm Introduction and Business Overview
    Table 94. Dance Biopharm Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Dance Biopharm Insulin Dosing Device Product Offerings
    Table 96. Dance Biopharm Recent Development
    Table 97. Debiotech Company Information
    Table 98. Debiotech Introduction and Business Overview
    Table 99. Debiotech Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Debiotech Insulin Dosing Device Product Offerings
    Table 101. Debiotech Recent Development
    Table 102. Insulet Company Information
    Table 103. Insulet Introduction and Business Overview
    Table 104. Insulet Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Insulet Insulin Dosing Device Product Offerings
    Table 106. Insulet Recent Development
    Table 107. MannKind Company Information
    Table 108. MannKind Introduction and Business Overview
    Table 109. MannKind Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. MannKind Insulin Dosing Device Product Offerings
    Table 111. MannKind Recent Development
    Table 112. Owen Mumford Company Information
    Table 113. Owen Mumford Introduction and Business Overview
    Table 114. Owen Mumford Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Owen Mumford Insulin Dosing Device Product Offerings
    Table 116. Owen Mumford Recent Development
    Table 117. Roche Company Information
    Table 118. Roche Introduction and Business Overview
    Table 119. Roche Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Roche Insulin Dosing Device Product Offerings
    Table 121. Roche Recent Development
    Table 122. SOOIL Company Information
    Table 123. SOOIL Introduction and Business Overview
    Table 124. SOOIL Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. SOOIL Insulin Dosing Device Product Offerings
    Table 126. SOOIL Recent Development
    Table 127. Tandem Diabetes Care Company Information
    Table 128. Tandem Diabetes Care Introduction and Business Overview
    Table 129. Tandem Diabetes Care Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. Tandem Diabetes Care Insulin Dosing Device Product Offerings
    Table 131. Tandem Diabetes Care Recent Development
    Table 132. Valeritas Company Information
    Table 133. Valeritas Introduction and Business Overview
    Table 134. Valeritas Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. Valeritas Insulin Dosing Device Product Offerings
    Table 136. Valeritas Recent Development
    Table 137. West Pharma Company Information
    Table 138. West Pharma Introduction and Business Overview
    Table 139. West Pharma Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 140. West Pharma Insulin Dosing Device Product Offerings
    Table 141. West Pharma Recent Development
    Table 142. Ypsomed Company Information
    Table 143. Ypsomed Introduction and Business Overview
    Table 144. Ypsomed Insulin Dosing Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 145. Ypsomed Insulin Dosing Device Product Offerings
    Table 146. Ypsomed Recent Development
    Table 147. Key Raw Materials Lists
    Table 148. Raw Materials Key Suppliers Lists
    Table 149. Insulin Dosing Device Downstream Customers
    Table 150. Insulin Dosing Device Distributors List
    Table 151. Research Programs/Design for This Report
    Table 152. Key Data Information from Secondary Sources
    Table 153. Key Data Information from Primary Sources
List of Figures
    Figure 1. Insulin Dosing Device Product Picture
    Figure 2. Global Insulin Dosing Device Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Insulin Dosing Device Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Insulin Dosing Device Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Insulin Dosing Device Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Insulin Dosing Device Report Years Considered
    Figure 7. Global Insulin Dosing Device Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Insulin Dosing Device Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Insulin Dosing Device Revenue in 2023
    Figure 10. Insulin Dosing Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Insulin Pens Picture
    Figure 12. Insulin Pumps Picture
    Figure 13. Insulin Syringes Picture
    Figure 14. Others Picture
    Figure 15. Global Insulin Dosing Device Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Insulin Dosing Device Sales Value Market Share by Type, 2023 & 2030
    Figure 17. Global Insulin Dosing Device Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 18. Global Insulin Dosing Device Sales Volume Market Share by Type, 2023 & 2030
    Figure 19. Global Insulin Dosing Device Price by Type (2019-2030) & (US$/Unit)
    Figure 20. Product Picture of Hospital
    Figure 21. Product Picture of Clinic
    Figure 22. Product Picture of Home Care
    Figure 23. Product Picture of Others
    Figure 24. Global Insulin Dosing Device Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 25. Global Insulin Dosing Device Sales Value Market Share by Application, 2023 & 2030
    Figure 26. Global Insulin Dosing Device Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 27. Global Insulin Dosing Device Sales Volume Market Share by Application, 2023 & 2030
    Figure 28. Global Insulin Dosing Device Price by Application (2019-2030) & (US$/Unit)
    Figure 29. North America Insulin Dosing Device Sales Value (2019-2030) & (US$ Million)
    Figure 30. North America Insulin Dosing Device Sales Value by Country (%), 2023 VS 2030
    Figure 31. Europe Insulin Dosing Device Sales Value (2019-2030) & (US$ Million)
    Figure 32. Europe Insulin Dosing Device Sales Value by Country (%), 2023 VS 2030
    Figure 33. Asia Pacific Insulin Dosing Device Sales Value (2019-2030) & (US$ Million)
    Figure 34. Asia Pacific Insulin Dosing Device Sales Value by Country (%), 2023 VS 2030
    Figure 35. South America Insulin Dosing Device Sales Value (2019-2030) & (US$ Million)
    Figure 36. South America Insulin Dosing Device Sales Value by Country (%), 2023 VS 2030
    Figure 37. Middle East & Africa Insulin Dosing Device Sales Value (2019-2030) & (US$ Million)
    Figure 38. Middle East & Africa Insulin Dosing Device Sales Value by Country (%), 2023 VS 2030
    Figure 39. Key Countries/Regions Insulin Dosing Device Sales Value (%), (2019-2030)
    Figure 40. Key Countries/Regions Insulin Dosing Device Sales Volume (%), (2019-2030)
    Figure 41. United States Insulin Dosing Device Sales Value, (2019-2030) & (US$ Million)
    Figure 42. United States Insulin Dosing Device Sales Value by Type (%), 2023 VS 2030
    Figure 43. United States Insulin Dosing Device Sales Value by Application (%), 2023 VS 2030
    Figure 44. Europe Insulin Dosing Device Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Europe Insulin Dosing Device Sales Value by Type (%), 2023 VS 2030
    Figure 46. Europe Insulin Dosing Device Sales Value by Application (%), 2023 VS 2030
    Figure 47. China Insulin Dosing Device Sales Value, (2019-2030) & (US$ Million)
    Figure 48. China Insulin Dosing Device Sales Value by Type (%), 2023 VS 2030
    Figure 49. China Insulin Dosing Device Sales Value by Application (%), 2023 VS 2030
    Figure 50. Japan Insulin Dosing Device Sales Value, (2019-2030) & (US$ Million)
    Figure 51. Japan Insulin Dosing Device Sales Value by Type (%), 2023 VS 2030
    Figure 52. Japan Insulin Dosing Device Sales Value by Application (%), 2023 VS 2030
    Figure 53. South Korea Insulin Dosing Device Sales Value, (2019-2030) & (US$ Million)
    Figure 54. South Korea Insulin Dosing Device Sales Value by Type (%), 2023 VS 2030
    Figure 55. South Korea Insulin Dosing Device Sales Value by Application (%), 2023 VS 2030
    Figure 56. Southeast Asia Insulin Dosing Device Sales Value, (2019-2030) & (US$ Million)
    Figure 57. Southeast Asia Insulin Dosing Device Sales Value by Type (%), 2023 VS 2030
    Figure 58. Southeast Asia Insulin Dosing Device Sales Value by Application (%), 2023 VS 2030
    Figure 59. India Insulin Dosing Device Sales Value, (2019-2030) & (US$ Million)
    Figure 60. India Insulin Dosing Device Sales Value by Type (%), 2023 VS 2030
    Figure 61. India Insulin Dosing Device Sales Value by Application (%), 2023 VS 2030
    Figure 62. Insulin Dosing Device Industrial Chain
    Figure 63. Insulin Dosing Device Manufacturing Cost Structure
    Figure 64. Channels of Distribution (Direct Sales, and Distribution)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed

Description

The global market for Insulin Dosing Device was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Insulin Dosing Device, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Insulin Dosing Device by region & country, by Type, and by Application.

The Insulin Dosing Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Dosing Device.

Market Segmentation